Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Crossless retroviral vectors

Crossless retroviral vectors

US Patent 6013517 · Granted Jan 11, 2000

Estimated economic value: $45,852,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods and compositions comprising tumor suppressor gene therapy and CD122/CD132025
DNA molecules encoding antibodies to tau and methods of making thereof2020
Vectors conditionally expressing therapeutic proteins, host cells comprising the2020
Antibodies to tau and methods of treatment therewith2018
Antibodies to tau and uses thereof2016
Fibroblast growth factor 21 variant, composition , and uses thereof2016
Vectors conditionally expressing protein2016
Fibroblast growth factor 21 proteins2015
Fibroblast growth factor 21 variants2014
Fibroblast growth factor 21 proteins2014
P53 vaccines for the treatment of cancers2014
Compositions and methods for generating an immune response utilizing alphavirus-2014